Medical Science News

RSS

Computational model predicts telomere length from biopsy images

A new computational tool infers changes occurring at the ends of the chromosomes housing our DNA. It does so by detecting structural alterations in cells and tissues captured in images taken of routine medical biopsies, according to findings published March 16, 2026, in Cell Reports Methods.

16 Mar 2026

New 3D-printed medicated patches show promise for chronic wound healing

A team of University of Mississippi researchers is developing a way to use 3D printed medicated patches to help close persistent sores and ulcers.

16 Mar 2026

New study links storytelling to evolution of human memory

New research from the University of Mississippi suggests that telling stories – from ancient campfire tales to modern-day digital communication – may be tied to how human memory evolved.

16 Mar 2026

Innovative platform detects diseases using a single drop of blood

An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing diseases from as little as 50 μl of human plasma, or roughly a drop of blood.

16 Mar 2026

Boosting noradrenaline during learning makes the brain link memories more broadly, study finds

A randomized placebo controlled experiment shows that increasing noradrenaline during learning does not improve basic memory accuracy but increases the spread of associations across the hippocampal cognitive map. This broader neural linking leads to greater overgeneralization errors days later, suggesting that noradrenergic arousal can reshape how related memories become interconnected.

16 Mar 2026

Sleep-like brain activity linked to attention lapses in ADHD

New from JNeurosci, Elaine Pinggal, from Monash University, and colleagues assessed how sleep-like brain activity in awake adults influences sustained attention during a task.

16 Mar 2026

Study maps gene activity linked to neurotransmission in living brains

Researchers have identified a distinct and reproducible gene expression program associated with neurotransmission in the living human brain, offering unprecedented insight into the molecular mechanisms that support human cognition, emotion, and behavior.

16 Mar 2026

New insight into origins of rare liver tumors in children

Liver cancer in children is rare, but when it occurs the two main types are hepatoblastoma (HB) and hepatocellular carcinoma (HCC).

16 Mar 2026

Study explains how the brain focuses on a single voice in noisy environment

MIT neuroscientists have figured out how the brain is able to focus on a single voice among a cacophony of many voices, shedding light on a longstanding neuroscientific phenomenon known as the cocktail party problem.

16 Mar 2026

New CAR-NKT cell therapy shows promise against aggressive endometrial cancer

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades.

16 Mar 2026

Alcohol consumption in early adulthood linked to middle age cognitive decline

It's well known that alcohol consumption is an age-old method for coping with stress. But surprising? research led by the University of Massachusetts Amherst found that, when such self-medication begins in early adulthood, negative cognitive effects start to show up in middle-age-even after long periods of total abstinence.

16 Mar 2026

Brain breathing mechanism linked to persistent high blood pressure

A brain mechanism may explain why approximately 40% of people with hypertension continue to have high blood pressure despite taking medication. The discovery reveals potential targets for new treatments.

16 Mar 2026

Scientists identify common symptom patterns in post-COVID-19 vaccination syndrome

A registry study across 14 Japanese clinics analyzed 179 cases of post-COVID-19 vaccination syndrome (PCVS) and identified 493 adverse events affecting multiple organ systems. Most symptoms appeared within 90 days, but some occurred much later, highlighting the need for continued vaccine safety monitoring and better clinical frameworks for persistent post-vaccination symptoms.

16 Mar 2026

Protein MIIP suppresses colorectal cancer by regulating immune cell signaling

Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, largely due to metastasis and limited responses to immunotherapy in most patients.

16 Mar 2026

Researchers develop targeted delivery system for poorly soluble cancer drugs

Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high therapeutic efficacy.

16 Mar 2026

Clinicians show modest response to elevated lipoprotein levels in low-risk patients

Elevated Lipoprotein(a) [Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels >50 mg/dL affecting 20–30% of the global population.

16 Mar 2026

Gold nanoclusters may help detect diseases from blood samples

An extensive computational study by researchers from the University of Jyväskylä (Finland) predicted that gold nanoclusters could selectively recognize chiral biomolecules.

16 Mar 2026

Brain waste clearance dysfunction may predict the onset of psychosis

How can we explain the onset of psychotic symptoms characteristic of schizophrenia? Despite their major and often irreversible impact on intellectual abilities and autonomy, the biological mechanisms that precede their emergence remain poorly understood.

16 Mar 2026

Can Ashwagandha gummies help kids focus better?

A study shows Ashwagandha gummies may enhance cognitive performance and sleep quality in children, offering a safe herbal approach to support development.

16 Mar 2026

Why do some people respond better to GLP-1 drugs? Gut microbiome may hold clues

A review in the Canadian Journal of Physiology and Pharmacology examines emerging evidence linking glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the gut microbiome, and obesity treatment outcomes. The authors conclude that microbiome changes seen during therapy are most likely driven by diet, behavior, and weight loss, although microbial profiling may eventually help predict patient responses.

15 Mar 2026